Pharmaceutical Industry in United States: Industry Analysis, Forecast, Competition Mapping and Market Trends Assessment, 2011-2015

03-Jul-2011 | News-Press Release

The U.S. pharmaceutical industry, its historical performance and future trends for various segments as well as overall market. Competitive analysis of leading companies is also presented with focus on threats from generics. Reports also presents in detail the supply chain analysis of the U.S. pharmaceutical industry. Also covered in the report are the market trends, growth drivers and constraints, and an assessment of M&A activity in recent years.
 
 Table of Contents:
 
 1. Introduction
 1.1. Key Takeaways
 1.2. Research Methodology
 1.3. Industry Definition
 
 2. U.S. Healthcare Sector
 
 3. Industry Overview
 3.1. Global Pharmaceutical Industry
 3.2. U.S. Pharmaceutical Industry
 3.3. Industry Segmentation
 3.3.1. Oncologies
 3.3.2. Respiratory
 3.3.3. Lipid Regulators
 3.3.4. Anti-Diabetes
 3.3.5. Anti-Psychotic
 3.4. Industry Forecast
 
 4. Generic Drugs Market Assessment
 4.1. Legislative Origin of Generic Drugs
 4.2. Generic Drug Pricing
 4.3. Generic Industry Trends
 4.4. API Manufacturing Industry
 
 5. Distribution and Supply Chain Analysis
 5.1. Pharmaceutical Manufacturers
 5.2. Wholesale Distributors
 5.3. Pharmacies
 5.4. Pharmacy Benefit Managers (PBMs)
 
 6. Trend Analysis
 6.1. Generics Market Continues to Evolve
 6.2. Soaring Prices of Branded Prescription Drugs
 6.3. Growth in R&D Spending
 6.4. Growing Pharmaceutical Outsourcing Market
 6.5. Focus on Pharmerging or Emerging Markets
 6.6. Growing Trends towards IT Outsourcing
 
 7. Growth Drivers and Constraints
 7.1. Patents and Intellectual Property Rights
 7.2. Competition from International Players
 7.3. Industry Consolidation
 7.4. Aging Populations
 7.5. Technological Developments
 7.6. Changing Consumer Profile and Decreasing Influence
 7.7. Liability Issues
 7.8. Corporate Social Responsibility
 
 8. Government Policies and Regulations
 8.1. Healthcare Reforms of 2010
 8.2. Health Care and Education Reconciliation Act of 2010
 8.3. Expanded & Improved Medicare for All Act (H.R. 676)
 8.4. FDA Approvals Process
 8.5. Drug Price Competition and Patent Term Restoration Act
 8.6. Regulation for Drug Distribution
 8.7. Import and Re-Import of Prescription Drugs
 
 9. Competitive Landscape
 9.1. Competition Overview
 9.2. Analysis of Key Players
 9.2.1. Pfizer Inc.
 9.2.2. Merck & Co., Inc.
 9.2.3. AstraZeneca Plc
 9.2.4. Novartis AG
 9.2. 5. Eli Lilly & Co.
 
 10. Mergers & Acquisitions Assessment
 

 
For more information kindly visit :
 http://www.bharatbook.com/detail.asp?id=201781&rt=Pharmaceutical-Industry-in-United-States-Industry-Analysis-Forecast-Competition-Mapping-and-Market-Trends-Assessment-2011-2015.html
 
 Related Reports
 
 Oil and Chemicals Storage Industry Outlook in North America, 2011 - Capacity Analysis, Forecasts and Details of All Operating and Planned Storage Terminals to 2015 
 http://www.bharatbook.com/detail.asp?id=147895&rt=Oil-and-Chemicals-Storage-Industry-Outlook-in-North-America-2011-Capacity-Analysis-Forecasts-and-Details-of-All-Operating-and-Planned-Storage-Terminals-to-2015.html
 

 
Global Top 10 Personal Products - Industry, Financial and SWOT Analysis 
 
http://www.bharatbook.com/detail.asp?id=141512&rt=Global-Top-10-Personal-Products-Industry-Financial-and-SWOT-Analysis.html
 
 -30-
 

 
Or
 
 Contact us at :
 
 Bharat Book Bureau
 Tel: +91 22 27578668
 Fax: +91 22 27579131
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: http://twitter.com/#!/BharatBook
 Please visit our blog at http://bharatresearch.wordpress.com

Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Message
Login to Submit Email

Author Info

Tag Cloud

Categories

More Releases

Comments

Add a Comment

    \n\